
AFI Technology aims to realize the dream of extracting only desired cells undamaged from a multitude of cells. Founded in 2013, the company specializes in rapid microbial testing devices. Their key products include the ELS 005 PixeeMo-nX, a complete model with AI automatic counting and species estimation for rapid quantitative detection of viable cell counts, and ELESTA® PixeeMo®, which uses an innovative separation technology combining flow cytometry and solid-phase cytometry. They also offer the CROSSORTER®, a label-free cell separation and analysis system applicable in regenerative medicine, clinical testing, and beyond. AFI Technology's innovative electrode filter technology, AMATAR™, allows for the isolation, capture, and quantitative detection of viable bacteria from samples that are difficult to measure with conventional methods. The company is working to improve quality control across various industries including pharmaceuticals, clinical, cosmetics, healthcare, food and beverage, and environment.

AFI Technology aims to realize the dream of extracting only desired cells undamaged from a multitude of cells. Founded in 2013, the company specializes in rapid microbial testing devices. Their key products include the ELS 005 PixeeMo-nX, a complete model with AI automatic counting and species estimation for rapid quantitative detection of viable cell counts, and ELESTA® PixeeMo®, which uses an innovative separation technology combining flow cytometry and solid-phase cytometry. They also offer the CROSSORTER®, a label-free cell separation and analysis system applicable in regenerative medicine, clinical testing, and beyond. AFI Technology's innovative electrode filter technology, AMATAR™, allows for the isolation, capture, and quantitative detection of viable bacteria from samples that are difficult to measure with conventional methods. The company is working to improve quality control across various industries including pharmaceuticals, clinical, cosmetics, healthcare, food and beverage, and environment.